Literature DB >> 2194689

International travel and HIV infection.

C F von Reyn1, J M Mann, J Chin.   

Abstract

Although human immunodeficiency virus (HIV) infection is a worldwide problem, its prevalence and pattern vary from country to country. Accordingly, the risk to international travellers of acquiring HIV infection also varies widely in different parts of the world, and depends principally on their behaviour. The risk of sexual acquisition of HIV infection can be virtually eliminated by avoiding penetrative sexual intercourse with intravenous drug users and persons who have had multiple sexual partners (such as prostitutes) or reduced by the use of condoms. The risk of parenteral exposure to HIV can be reduced by avoiding parenteral drug use and behaviour that is likely to lead to injury (with its attendant risk of requiring blood transfusion) and by seeking medical facilities with adequate capabilities to screen blood donors for HIV and to sterilize instruments. HIV screening of international travellers is an ineffective, costly, and impractical public health strategy for limiting the worldwide spread of HIV infection. Travellers infected with HIV require specialized advice regarding health precautions, prophylactic medications, and immunization.

Entities:  

Mesh:

Year:  1990        PMID: 2194689      PMCID: PMC2393114     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  26 in total

1.  Antibody to human immunodeficiency virus in female prostitutes.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1987-03-27       Impact factor: 17.586

2.  Recommendations for prevention of HIV transmission in health-care settings.

Authors: 
Journal:  MMWR Suppl       Date:  1987-08-21

3.  Transmission of HIV in Belle Glade, Florida: lessons for other communities in the United States.

Authors:  K G Castro; S Lieb; H W Jaffe; J P Narkunas; C H Calisher; T J Bush; J J Witte
Journal:  Science       Date:  1988-01-08       Impact factor: 47.728

4.  Screening for HIV: can we afford the false positive rate?

Authors:  K B Meyer; S G Pauker
Journal:  N Engl J Med       Date:  1987-07-23       Impact factor: 91.245

Review 5.  Salmonellosis during infection with human immunodeficiency virus.

Authors:  S J Sperber; C J Schleupner
Journal:  Rev Infect Dis       Date:  1987 Sep-Oct

Review 6.  Cultural practices contributing to the transmission of human immunodeficiency virus in Africa.

Authors:  D B Hrdy
Journal:  Rev Infect Dis       Date:  1987 Nov-Dec

Review 7.  Use of pyrimethamine-sulfadoxine (Fansidar) in prophylaxis against chloroquine-resistant Plasmodium falciparum and Pneumocystis carinii.

Authors:  R D Pearson; E L Hewlett
Journal:  Ann Intern Med       Date:  1987-05       Impact factor: 25.391

8.  Ciprofloxacin or trimethoprim-sulfamethoxazole as initial therapy for travelers' diarrhea. A placebo-controlled, randomized trial.

Authors:  C D Ericsson; P C Johnson; H L Dupont; D R Morgan; J A Bitsura; F J de la Cabada
Journal:  Ann Intern Med       Date:  1987-02       Impact factor: 25.391

Review 9.  Human immunodeficiency virus infection and routine childhood immunisation.

Authors:  C F von Reyn; C J Clements; J M Mann
Journal:  Lancet       Date:  1987-09-19       Impact factor: 79.321

10.  AIDS--A global perspective. Global epidemiology.

Authors:  C F Von Reyn; J M Mann
Journal:  West J Med       Date:  1987-12
View more
  4 in total

1.  Statement on travellers and sexually transmitted diseases.

Authors: 
Journal:  CMAJ       Date:  1995-06-01       Impact factor: 8.262

2.  Knowledge and beliefs of international travellers about the transmission and prevention of HIV infection.

Authors:  R Allard; G Lambert
Journal:  CMAJ       Date:  1992-02-01       Impact factor: 8.262

3.  Preparation of the HIV-infected Traveler to the Tropics.

Authors:  Christopher L. Karp
Journal:  Curr Infect Dis Rep       Date:  2001-02       Impact factor: 3.663

Review 4.  Immunizations for foreign travel.

Authors:  D R Hill
Journal:  Yale J Biol Med       Date:  1992 Jul-Aug
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.